Multi-Manager Framework: Greenwald + Dalio + Soros + Druckenmiller + Laffont + Ackman + Cohen/Griffin
Generated: 2026-07-21 08:14:27 · EDGAR + yfinance
SGMA trades at 0% premium to EPV, the market is pricing in significant growth. Grade D quality (EQ 2/10). ROIC below WACC, growth may destroy value. Greenwald red flag.
Neutral setup, no strong reflexivity signal. Limited catalysts visible. Monitor for Stage 2 entry signal. Patience is a position.
| Ticker | Rationale | Mkt Cap | EV/EBITDA TTM | EV/EBIT TTM | EV/Rev TTM | EV/FCF TTM | Fwd P/E FWD | EBITDA Mg TTM | Rev Gr. YoY | ND/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|
| AAPL ✓ | Benchmark: Apple, $3T market cap proxy for br | $4.8T | 37.2x | N/A | 12.5x | 47.7x | 33.9x | +34% | +3% | 0.7x |
| MSFT ✓ | Benchmark: Microsoft, diversified tech; cloud | $3.0T | 28.3x | N/A | 14.1x | 47.7x | 20.8x | +50% | +14% | 0.4x |
| JNJ ✓ | Benchmark: J&J, diversified healthcare; defen | $599B | 23.4x | N/A | 7.7x | 34.5x | 19.4x | +33% | +5% | 1.5x |
| PG ✓ | Benchmark: Procter & Gamble, consumer staples | $347B | 18.0x | N/A | 4.7x | 26.1x | 21.1x | +26% | +3% | 1.2x |
| JPM ✓ | Benchmark: JPMorgan, financials baseline; eco | $901B | N/A | N/A | 14.5x | N/A | 13.7x | N/A | +11% | N/A |
| Peer Median | N/A | 25.9x | N/A | 12.5x | 41.1x | 20.8x | +33% | N/A | 0.9x | |
| Subject Company | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Base EBIT (Operating Income) TTM | $0 |
| Adjusted EBIT | $0 |
| Quality Haircut (earnings-quality grade) | -15% |
| × (1 − Tax Rate) (25% statutory) | $0 |
| Sustainable NOPAT ÷ WACC (11.6%) | $0 |
| 1 | Base EBIT (Operating Income) | $0 | From income statement |
| 2 | = Adjusted EBIT | $0 | |
| 3 | Quality Haircut (15%) | -15% | Based on earnings quality grade |
| 4 | x (1 - Tax Rate) | 25% statutory | |
| = | Sustainable NOPAT | $0 | Net Operating Profit After Tax |
| / | WACC (11.6%) | Weighted average cost of capital | |
| = | EPV Operating | $0 | Enterprise value on no-growth basis |
| + | Cash | +$0 | |
| - | Total Debt | -$0 | |
| = | EPV of Equity | $0 | |
| / | Shares Outstanding | 6M | |
| = | EPV Per Share | $0 | vs. Market Price $3.01 |
| Ticker | Rationale | Mkt Cap | EV/EBITDA TTM | EV/EBIT TTM | EV/Rev TTM | EV/FCF TTM | Fwd P/E FWD | EBITDA Mg TTM | Rev Gr. YoY | ND/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|
| AAPL ✓ | Benchmark: Apple, $3T market cap proxy for br | $4.8T | 37.2x | N/A | 12.5x | 47.7x | 33.9x | +34% | +3% | 0.7x |
| MSFT ✓ | Benchmark: Microsoft, diversified tech; cloud | $3.0T | 28.3x | N/A | 14.1x | 47.7x | 20.8x | +50% | +14% | 0.4x |
| JNJ ✓ | Benchmark: J&J, diversified healthcare; defen | $599B | 23.4x | N/A | 7.7x | 34.5x | 19.4x | +33% | +5% | 1.5x |
| PG ✓ | Benchmark: Procter & Gamble, consumer staples | $347B | 18.0x | N/A | 4.7x | 26.1x | 21.1x | +26% | +3% | 1.2x |
| JPM ✓ | Benchmark: JPMorgan, financials baseline; eco | $901B | N/A | N/A | 14.5x | N/A | 13.7x | N/A | +11% | N/A |
| Peer Median | N/A | 25.9x | N/A | 12.5x | 41.1x | 20.8x | +33% | N/A | 0.9x | |
| Subject Company | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |